Why Livongo Health's Stock Is Trading Higher Today

Livongo Health LVGO shares are trading higher on Tuesday after DA Davidson initiated coverage on Teladoc with a Buy rating and $250 price target. Teladoc and Livongo announced a merger agreement this year.

Livongo Health provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.

Livongo Health shares were trading up 5.42% at $137.59 on Tuesday at the time of publication. The stock has a 52-week high of $150 and a 52-week low of $15.12.